Screener
Amphastar Pharmaceuticals AMPH Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Inventories | 179,907 | 176,890 |
| Income tax refunds and deposits | 2,628 | 17,167 |
| Prepaid expenses and other assets | 11,001 | 13,152 |
| Total current assets | 630,951 | 636,016 |
| Property, plant, and equipment, net | 316,063 | 310,567 |
| Finance lease right-of-use assets | 152 | 221 |
| Operating lease right-of-use assets | 72,911 | 42,931 |
| Goodwill and intangible assets, net | 647,833 | 565,965 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Amphastar Pharmaceuticals's total current assets?
- Amphastar Pharmaceuticals (AMPH) reported total current assets of $630.95M in Q2 2026.
- How has Amphastar Pharmaceuticals's total current assets changed year-over-year?
- Amphastar Pharmaceuticals's total current assets increased by 8.6% year-over-year, from $580.83M to $630.95M.
- What is the long-term trend for Amphastar Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's total current assets has grown at a 17.9% compound annual growth rate (CAGR), from $279.68M to $636.02M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Amphastar Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude